[조사자료] 글로벌 세포주 개발 시장 (2023-2030) : 시약 및 배지, 기기

■ 영문 제목 : Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023 - 2030
	■ 상품코드 : GRV23NOV010 ■ 조사/발행회사 : Grand View Research ■ 발행일 : 2023년 9월 ■ 페이지수 : 180 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (납기:3일) ■ 조사대상 지역 : 세계 ■ 산업 분야 : 바이오

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD5,950 ⇒환산￦8,032,500	견적의뢰/주문/질문
Multi User (5인 열람용)	USD6,950 ⇒환산￦9,382,500	견적의뢰/주문/질문
Global/corporate License (기업 열람용)	USD8,950 ⇒환산￦12,082,500	견적의뢰/구입/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 세포주 개발 시장의 성장과 동향
Grand View Research사의 최신 보고서에 따르면, 세계의 세포주 개발 시장 규모는 2030년까지 100. 9억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균 9. 81%의 성장률을 보일 것으로 예측됩니다. 세포주 개발(CLD) 시장 확대를 촉진하는 주요 요인 중 하나는 특히 코로나 바이러스 확산 이후 전 세계적으로 백신 생산이 증가하고 있다는 점입니다. 새로운 의료 기술의 사용 증가와 암 발병률의 증가는 CLD 시장에 더 매력적이고 유리한 성장 전망을 제공하고 있습니다. 생물학적 제제 분야의 확대와 성장도 CLD 시장 발전의 주요 결정 요인이 될 것으로 보입니다.

기술적으로 개선된 CLD 치료제의 출시가 증가하는 것도 시장 확대의 원동력이 될 것으로 보입니다. 예를 들어, BICO의 자회사 CYTENA는 2021년 10월에 완전 자동화된 안정적인 세포주 개발을 위한 새로운 플랫폼을 발표했습니다. 비용 효율적이고 더 나은 실험실 자동화를 가능하게 하는 이 시스템은 CYTENA의 동급 최고의 액체 취급 정보와 기존의 확립된 단일 세포 주입 기술을 통합한 것으로, BICO의 Bio Convergence agenda는 항체 치료, 유전자 치료, 바이오시밀러 제조와 같은 차세대 의료 서비스 개발의 접근성을 향상시킬 것으로 보입니다. 바이오시밀러 제조 등 차세대 의료 서비스 발전에 대한 접근성 확대를 통해 추진됩니다.

또한 2021년 7월 의약품 제조 관련 최신 정보에 따르면, Novartis의 Entresto와 Biogen의 Spinraza를 포함한 블록버스터를 포함한 약 20개의 의약품이 2023년에 특허가 만료됩니다. 오리지널 의약품의 특허 만료는 바이오시밀러의 탄생을 가져왔습니다. 이에 따라 세포주 개발의 필요성이 높아지고 있습니다. 따라서 시장 성장의 원동력이 될 것으로 보입니다.

또한, 제휴, 확장, 인수 등 기업 전략의 성장도 시장 성장의 원동력이 되고 있습니다. 예를 들어, ProBioGen과 Granite Bio는 2022년 7월 GMP 제조 및 세포주 개발 솔루션을 제공하고 Granite Bio의 mAb 파이프라인 개발을 지원하기 위해 제휴를 맺었습니다. 마찬가지로 2022년 6월, 후지필름은 후지필름 디오신스 바이오테크놀로지의 세포 배양 생산 능력을 개선하고 확장하기 위해 16억 달러를 투자할 것이라고 발표했습니다. 또한 2022년 10월, Cytiva는 첨단 CLD 및 바이러스 벡터 제조 기술의 저명한 독일 제조업체인 CEVEC Pharmaceuticals를 인수했습니다. 이 개발을 통해 CEVEC는 Cytiva가 바이오 제조 기술에서 선도적인 지위를 유지하는 데 도움이 될 것으로 보입니다.

그러나 R&D 역량을 구축하는 데 필요한 높은 자본 비용과 지출은 세포주 개발 산업의 장벽이 될 수 있습니다.

세포주 개발 시장 보고서 주요 내용

- 제품별로는 시약 및 배지 부문이 2022년 43. 78%로 가장 큰 점유율을 차지했습니다. 비용 집약적인 특성과 생물학적 제제 제조에 자주 사용되기 때문에 이 품목이 가장 큰 수익 점유율을 차지했습니다.

- 공급원별로는 포유류 세포주 부문이 2022년 72. 62%로 가장 큰 점유율을 차지했습니다. 포유류 세포주는 인간과 동일한 복잡한 단백질을 발현할 수 있기 때문에 포유류 세포주를 통해 바이오 의약품을 효율적으로 생산할 수 있어 빠르게 성장하고 있습니다.

- 세포주 유형별로는 바이오의약품 제조 공정, 유전자 활성화, 단백질 상호작용 등에 광범위하게 적용되면서 재조합 세포주 기업이 2022년 31. 79%로 가장 큰 점유율을 차지할 것으로 보입니다.

- 용도별로는 바이오 생산 부문이 2022년 46. 30%로 가장 큰 점유율을 차지했습니다. 체외 연구 활동의 증가, 제품 안전성 및 효능에 대한 우려, 바이오시밀러 수요, 세포치료제 수요 증가 등의 요인이 바이오 생산 산업을 주도하고 있습니다.

- 북미 지역이 2022년 39. 22%로 가장 큰 점유율을 차지할 것으로 예상되는데, 이는 지속적인 기술 개선과 더불어 새로운 발견이 바이오 생산을 위한 새로운 공정 채택에 불을 지폈기 때문으로 분석됩니다. Corporation, American Type Culture Collection (ATCC) 등 고품질의 CLD 서비스를 제공하는 이 지역 연구 기업들의 엄격한 활동이 성장에 기여하고 있습니다.

- 주요 기업으로는 Thermo Fisher Scientific Inc., Corning Inc., Lonza, Creative BioLabs, WuXi PharmaTech, Sartorius AG, Merck KGaA, Advanced Instruments, Berkeley Lights, Danaher 등이 있습니다.

■ 보고서 개요

Chapter 1. 조사 방법 및 범위
Chapter 2. 개요
Chapter 3. 시장 변수/동향/범위
Chapter 4. 세계의 세포주 개발 시장 : 제품 및 서비스별 분석
Chapter 5. 세계의 세포주 개발 시장 : 공급원별 분석
Chapter 6. 세계의 세포주 개발 시장 : 세포주 유형별 분석
Chapter 7. 세계의 세포주 개발 시장 : 용도별 분석
Chapter 8. 세계의 세포주 개발 시장 : 지역별 분석
Chapter 9. 경쟁 현황

■ 보고서 목차

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information analysis
1.2.2. Market formulation & data visualization
1.2.3. Data validation & publishing
1.3. Information Procurement
1.3.1. Primary Others
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Market Model
1.7. Objectives
1.7.1. Objective 1
1.7.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Patent expiration of blockbuster biologics
3.3.2. Rising demand for monoclonal antibodies
3.3.3. Increasing vaccine production
3.3.4. Technological advancement for the cell line development
3.3.5. Increasing prevalence of cancer
3.3.6. Growing R&D investments in biotechnology sector
3.4. Market Restraint Analysis
3.4.1. Presence of complicated regulatory framework
3.5. Business Environment Analysis
3.5.1. PESTEL Analysis
3.5.2. Porter’s Five Forces Analysis
3.5.3. COVID-19 Impact Analysis
Chapter 4. Product & Services Business Analysis
4.1. Global cell line development market: Product & Services Movement Analysis
4.2. Reagents and media
4.2.1. Reagents and media Market, 2018 – 2030 (USD Million)
4.3. Equipment
4.3.1. Equipment Market, 2018 – 2030 (USD Million)
4.3.2. Automated Systems
4.3.2.1. Automated Systems Market, 2018 – 2030 (USD Million)
4.3.3. Centrifuges
4.3.3.1. Centrifuges Market, 2018 – 2030 (USD Million)
4.3.4. Bioreactors
4.3.4.1. Bioreactors Market, 2018 – 2030 (USD Million)
4.3.5. Storage equipment
4.3.5.1. Storage equipment Market, 2018 – 2030 (USD Million)
4.3.6. Others
4.3.6.1. Others Market, 2018 – 2030 (USD Million)
4.4. Accessories and consumables
4.4.1. Accessories and consumables Market, 2018 – 2030 (USD Million)
4.5. Services
4.5.1. Services Market, 2018 – 2030 (USD Million)
Chapter 5. Source Business Analysis
5.1. Global cell line development market: Source Movement Analysis
5.2. Mammalian cell line
5.2.1. Mammalian cell line Market, 2018 – 2030 (USD Million)
5.3. Non-mammalian cell line
5.3.1. Non-mammalian cell line Market, 2018 – 2030 (USD Million)
5.3.2. Insects
5.3.2.1. Insects Market, 2018 – 2030 (USD Million)
5.3.3. Amphibians
5.3.3.1. Amphibians Market, 2018 – 2030 (USD Million)
Chapter 6. Type of Cell Lines Business Analysis
6.1. Global cell line development market: Type of Cell Lines Movement Analysis
6.2. Recombinant cell lines
6.2.1. Recombinant cell lines Market, 2018 – 2030 (USD Million)
6.3. Hybridomas
6.3.1. Hybridomas Market, 2018 – 2030 (USD Million)
6.4. Continuous cell lines
6.4.1. Continuous cell lines Market, 2018 – 2030 (USD Million)
6.5. Primary cell lines
6.5.1. Primary cell lines Market, 2018 – 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Global cell line development market: Application Movement Analysis
7.2. Bioproduction
7.2.1. Bioproduction Market, 2018 – 2030 (USD Million)
7.3. Drug discovery
7.3.1. Drug discovery Market, 2018 – 2030 (USD Million)
7.4. Toxicity testing
7.4.1. Toxicity testing Market, 2018 – 2030 (USD Million)
7.5. Tissue engineering
7.5.1. Tissue engineering Market, 2018 – 2030 (USD Million)
7.6. Others
7.6.1. Others Market, 2018 – 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Global Cell line development market Share By Region, 2022 & 2030
8.2. North America
8.2.1. North America cell line development market, 2018 – 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. Target Disease Prevalence
8.2.2.5. U.S. cell line development market, 2018 – 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Target Disease Prevalence
8.2.3.5. Canada cell line development market, 2018 – 2030 (USD Million)
8.3. Europe
8.3.1. Europe Cell line development market, 2018 – 2030 (USD Million)
8.3.2. Germany
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. Target Disease Prevalence
8.3.2.5. Germany cell line development market, 2018 – 2030 (USD Million)
8.3.3. UK
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Target Disease Prevalence
8.3.3.5. UK cell line development market, 2018 – 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. Target Disease Prevalence
8.3.4.5. France cell line development market, 2018 – 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Target Disease Prevalence
8.3.5.5. Italy cell line development market, 2018 – 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Target Disease Prevalence
8.3.6.5. Spain cell line development market, 2018 – 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Target Disease Prevalence
8.3.7.5. Denmark cell line development market, 2018 – 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Target Disease Prevalence
8.3.8.5. Sweden cell line development market, 2018 – 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Target Disease Prevalence
8.3.9.5. Norway cell line development market, 2018 – 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific cell line development market, 2018 – 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. Target Disease Prevalence
8.4.2.5. Japan cell line development market, 2018 – 2030 (USD Million)
8.4.3. China
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Target Disease Prevalence
8.4.3.5. China cell line development market, 2018 – 2030 (USD Million)
8.4.4. India
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Target Disease Prevalence
8.4.4.5. India cell line development market, 2018 – 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Target Disease Prevalence
8.4.5.5. South Korea cell line development market, 2018 – 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. Target Disease Prevalence
8.4.6.5. Australia cell line development market, 2018 – 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Target Disease Prevalence
8.4.7.5. Thailand cell line development market, 2018 – 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America cell line development market, 2018 – 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Target Disease Prevalence
8.5.2.5. Brazil cell line development market, 2018 – 2030 (USD Million)
8.5.3. Mexico
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Target Disease Prevalence
8.5.3.5. Mexico cell line development market, 2018 – 2030 (USD Million)
8.5.4. Argentina
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Target Disease Prevalence
8.5.4.5. Argentina cell line development market, 2018 – 2030 (USD Million)
8.6. MEA
8.6.1. MEA cell line development market, 2018 – 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Target Disease Prevalence
8.6.2.5. South Africa cell line development market, 2018 – 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. Target Disease Prevalence
8.6.3.5. Saudi Arabia cell line development market, 2018 – 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Target Disease Prevalence
8.6.4.5. UAE cell line development market, 2018 – 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Target Disease Prevalence
8.6.5.5. Kuwait cell line development market, 2018 – 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market/PositionShare Analysis, 2022
9.4. Company Profiles/Listing
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Product Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. Danaher
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Product Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. Merck KGaA
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Product Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Sartorius AG
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Product Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Lonza
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Product Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. WuXi PharmaTech
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Product Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. Advanced Instruments
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Product Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Berkeley Lights
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Product Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Creative BioLabs
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Product Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Corning Inc.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Product Benchmarking
9.4.10.4. Strategic Initiatives

List of Tables

Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Global Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 4 Global Cell line development market by Source, 2018 - 2030 (USD Million)
Table 5 Global Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 6 Global Cell line development market by Application, 2018 - 2030 (USD Million)
Table 7 North America Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 8 North America Cell line development market by Source, 2018 - 2030 (USD Million)
Table 9 North America Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 10 North America Cell line development market by Application, 2018 - 2030 (USD Million)
Table 11 North America Cell line development market by Country, 2018 - 2030 (USD Million)
Table 12 U.S. Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 13 U.S. Cell line development market by Source, 2018 - 2030 (USD Million)
Table 14 U.S. Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 15 U.S. Cell line development market by Application, 2018 - 2030 (USD Million)
Table 16 Canada Cell line development market by Source, 2018 - 2030 (USD Million)
Table 17 Canada Cell line development market by Source, 2018 - 2030 (USD Million)
Table 18 Canada Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 19 Canada Cell line development market by Application, 2018 - 2030 (USD Million)
Table 20 Europe Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 21 Europe Cell line development market by Source, 2018 - 2030 (USD Million)
Table 22 Europe Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 23 Europe Cell line development market by Application, 2018 - 2030 (USD Million)
Table 24 Europe Cell line development market by Country, 2018 - 2030 (USD Million)
Table 25 UK Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 26 UK Cell line development market by Source, 2018 - 2030 (USD Million)
Table 27 UK Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 28 UK Cell line development market by Application, 2018 - 2030 (USD Million)
Table 29 Germany Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 30 Germany Cell line development market by Source, 2018 - 2030 (USD Million)
Table 31 Germany Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 32 Germany Cell line development market by Application, 2018 - 2030 (USD Million)
Table 33 France Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 34 France Cell line development market by Source, 2018 - 2030 (USD Million)
Table 35 France Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 36 France Cell line development market by Application, 2018 - 2030 (USD Million)
Table 37 Italy Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 38 Italy Cell line development market by Source, 2018 - 2030 (USD Million)
Table 39 Italy Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 40 Italy Cell line development market by Application, 2018 - 2030 (USD Million)
Table 41 Spain Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 42 Spain Cell line development market by Source, 2018 - 2030 (USD Million)
Table 43 Spain Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 44 Spain Cell line development market by Application, 2018 - 2030 (USD Million)
Table 45 Denmark Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 46 Denmark Cell line development market by Source, 2018 - 2030 (USD Million)
Table 47 Denmark Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 48 Denmark Cell line development market by Application, 2018 - 2030 (USD Million)
Table 49 Sweden Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 50 Sweden Cell line development market by Source, 2018 - 2030 (USD Million)
Table 51 Sweden Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 52 Sweden Cell line development market by Application, 2018 - 2030 (USD Million)
Table 53 Norway Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 54 Norway Cell line development market by Source, 2018 - 2030 (USD Million)
Table 55 Norway Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 56 Norway Cell line development market by Application, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Cell line development market by Source, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Cell line development market by Application, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Cell line development market by Country, 2018 - 2030 (USD Million)
Table 62 China Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 63 China Cell line development market by Source, 2018 - 2030 (USD Million)
Table 64 China Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 65 China Cell line development market by Application, 2018 - 2030 (USD Million)
Table 66 Japan Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 67 Japan Cell line development market by Source, 2018 - 2030 (USD Million)
Table 68 Japan Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 69 Japan Cell line development market by Application, 2018 - 2030 (USD Million)
Table 70 India Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 71 India Cell line development market by Source, 2018 - 2030 (USD Million)
Table 72 India Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 73 India Cell line development market by Application, 2018 - 2030 (USD Million)
Table 74 South Korea Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 75 South Korea Cell line development market by Source, 2018 - 2030 (USD Million)
Table 76 South Korea Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 77 South Korea Cell line development market by Application, 2018 - 2030 (USD Million)
Table 78 Australia Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 79 Australia Cell line development market by Source, 2018 - 2030 (USD Million)
Table 80 Australia Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 81 Australia Cell line development market by Application, 2018 - 2030 (USD Million)
Table 82 Thailand Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 83 Thailand Cell line development market by Source, 2018 - 2030 (USD Million)
Table 84 Thailand Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 85 Thailand Cell line development market by Application, 2018 - 2030 (USD Million)
Table 86 Latin America Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 87 Latin America Cell line development market by Source, 2018 - 2030 (USD Million)
Table 88 Latin America Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 89 Latin America Cell line development market by Application, 2018 - 2030 (USD Million)
Table 90 Latin America Cell line development market by Country, 2018 - 2030 (USD Million)
Table 91 Brazil Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 92 Brazil Cell line development market by Source, 2018 - 2030 (USD Million)
Table 93 Brazil Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 94 Brazil Cell line development market by Application, 2018 - 2030 (USD Million)
Table 95 Mexico Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 96 Mexico Cell line development market by Source, 2018 - 2030 (USD Million)
Table 97 Mexico Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 98 Mexico Cell line development market by Application, 2018 - 2030 (USD Million)
Table 99 Argentina Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 100 Argentina Cell line development market by Source, 2018 - 2030 (USD Million)
Table 101 Argentina Cell line development market by Type of Cell Liner, 2018 - 2030 (USD Million)
Table 102 Argentina Cell line development market by Application, 2018 - 2030 (USD Million)
Table 103 Middle East & Africa Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 104 Middle East & Africa Cell line development market by Source, 2018 - 2030 (USD Million)
Table 105 Middle East & Africa Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 106 Middle East & Africa Cell line development market by Application, 2018 - 2030 (USD Million)
Table 107 Middle East & Africa Cell line development market by Country, 2018 - 2030 (USD Million)
Table 108 South Africa Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 109 South Africa Cell line development market by Source, 2018 - 2030 (USD Million)
Table 110 South Africa Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 111 South Africa Cell line development market by Application, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Cell line development market by Source, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Cell line development market by Application, 2018 - 2030 (USD Million)
Table 116 UAE Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 117 UAE Cell line development market by Source, 2018 - 2030 (USD Million)
Table 118 UAE Cell line development market by Type of Cell Line, 2018 - 2030 (USD Million)
Table 119 UAE Cell line development market by Application, 2018 - 2030 (USD Million)
Table 120 Kuwait Cell line development market by Product & Services, 2018 - 2030 (USD Million)
Table 121 Kuwait Cell line development market by Source, 2018 - 2030 (USD Million)
Table 122 Kuwait Cell line development market By Type of Cell Line, 2018 - 2030 (USD Million)
Table 123 Kuwait Cell line development market by Application, 2018 - 2030 (USD Million)
Table 124 Participant’s Overview
Table 125 Financial Performance
Table 126 Key Companies Undergoing Expansions
Table 127 Key Companies Undergoing Acquisitions
Table 128 Key Companies Undergoing Collaborations
Table 129 Key Companies Launching New Products/Services
Table 130 Key Companies Undergoing Partnerships
Table 131 Key Companies Undertaking Other Strategies

※본 조사보고서 [글로벌 세포주 개발 시장 (2023-2030) : 시약 및 배지, 기기] (코드 : GRV23NOV010) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 세포주 개발 시장 (2023-2030) : 시약 및 배지, 기기] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

글로벌 로봇 보조 내시경 시장 (2023-2030) : 병원, 외래 환자 시설
GRV23NOV241 / Grand View Research / 2023년 9월 / 글로벌 로봇 보조 내시경 시장의 성장과 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 로봇 보조 내시경 시장 규모는 2023년부터 2030년까지 연평균 8. 2%의 성장률을 기록하여 2030년에는 23억 6천만 달러에...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 로봇 보조 내시경 시장 : 최종 용도별 예측 및 동향 분석 Chapter 5. 세계의 로봇 보조 내시경 시장 : 지역별 예측 및 동향 분석 Chapter 6. 경쟁 현황...

글로벌 이상혈색소증 시장 (2023-2030) : 지중해 빈혈, 낫형 세포병, 기타 헤모글로빈 (Hb) 변종
GRV23NOV020 / Grand View Research / 2023년 9월 / 글로벌 이상혈색소증 시장의 성장 및 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 이상혈색소증 시장 규모는 2030년까지 207억 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 12. 6%의 연평균 성장률로 확대될 것으로...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변수/동향/범위 Chapter 4. 세계의 이상혈색소증 시장 : 유형별 분석 Chapter 5. 세계의 이상혈색소증 시장 : 진단별 분석 Chapter 6. 세계의 이상혈색소증 시장 : 치료법별 분석 Chapter 7. 세계의 이상혈색소증 시장 : 지역별 분석 Chapter 8. 경쟁 현황 Chapter...

세계의 아데노 수반 바이러스 벡터 제조 시장 (2023~2030) : 임상, 상업
GRV23MR008 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 아데노 수반 바이러스 벡터 제조 시장 규모가 2023년부터 2030년 사이에 CAGR 22.5% 증가하여, 2030년에는 39.5억 달러에 달할 것으로 예상하고 있습니다. 본...Adeno Associated Virus Vector Manufacturing Market Growth & Trends The global adeno associated virus vector manufacturing market size is expected to reach USD 3.95 billion by 2030, registering a CAGR of 22.5% over the forecast period, according to a new report by Grand View Research, Inc. This growth is attributed...

세계의 맞춤형 항체 시장 (2023~2030) : 단클론 항체, 폴리클로날 항체, 재조합 항체, 기타
GRV23MR076 / Grand View Research / 2023년 2월 / 미국 Grand View Research (그랜드뷰리서치)의 본 조사 보고서는 세계의 맞춤형 항체 시장 규모가 2023년부터 2030년 사이에 CAGR 9.7% 증가하여, 2030년에는 301.7백만 달러에 이를 것으로 예상하고 있습니다. 본 자료는 세계의 맞춤형...Custom Antibody Market Growth & Trends The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness substantial growth during...

글로벌 철결핍성 빈혈 치료 시장 (2023-2030) : 경구 철분 치료, 비경구 철분 치료
GRV23NOV276 / Grand View Research / 2023년 9월 / 글로벌 철결핍성 빈혈 치료 시장의 성장 및 동향 Grand View Research사의 최신 보고서에 따르면, 세계의 철결핍성 빈혈 치료 시장 규모는 2030년까지 80억 6천만 달러에 달할 것으로 예상되며, 2023년부터 2030년까지 연평균...Chapter 1. 조사 방법 및 범위 Chapter 2. 개요 Chapter 3. 시장 변동, 동향, 범위 Chapter 4. 세계의 철결핍성 빈혈 치료 시장 : 치료 유형별 예측 및 동향 분석 Chapter 5. 세계의 철결핍성 빈혈 치료 시장 : 연령대별 예측 및 동향 분석 Chapter 6. 세계의 철결핍성 빈혈 치료 시장 :...